Dong-A Pharm China as launching pad for pharmaceutical export boost

Published: 2007-02-08 06:59:00

Updated: 2007-02-08 06:59:00

Dong-A Pharm is gearing up to make inroads into China to capitalize on the China's growing demand for drugs and consolidate its leadership position in that country.

Dong-A said it recently inked an agreement to export $20 million worth of Stillen, the Korea's new anti-ulcerant, to China for th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK